MDS Virtual Congress 2020 Archives - Page 120 of 149

Calcitriol Treatment Attenuates Dopaminergic Neurodegeneration in Mice Model of Parkinson’s Disease

JJ. Hu, T. Wang (Wuhan, China)
Camptocormia in patients with multiple system atrophy with different disease durations

L.Y Zhang, B. Cao, QQ. Wei, R.W Ou, H.F Shang (Chengdu, China)
Can a “Shopping bag Tremor” be a Pre-diagnostic sign of Parkinson’s Disease?

B. Meira, J. Marto, R. Barbosa, M. Mendonça, P. Bugalho (Lisbon, Portugal)
Can bedside neurophysiological testing aid the differential diagnosis of bilateral upper limb action tremors in young-onset patients?

T. Dang, P. Panyakaew, R. Bhidayasiri (Ho Chi Minh, Viet Nam)
Can clinical outputs predict BDNF levels in people with Parkinson’s disease?

M. Delabary, E. Monteiro, A. Fagundes, M. Casal, A.P Zanardi, F. Boeno, S. Munhoz, R. de Menezes, A. de Oliveira, F. Martinez, L.A Tartaruga, A. Haas (Porto Alegre, Brazil)
Can Handwriting Movement Abnormalities Serve as an Early Biomarker of Transition to Manifest Huntington’s disease?

J. Corey-Bloom, A. Hall, C. Snell, B. Wright, M. Caligiuri (La Jolla, CA, USA)
Can post-operative local field potentials in the STN predict long-term DBS efficacy in Parkinson’s disease?

P.L Chen, H.T Wu, P.H Tu, Y.C Chen, C-C. Chen (Taoyuan City, Taiwan)
Can we customize tune for asymmetric tremor with differentiated Deep brain stimulation frequencies?

G. Baille, A. Kreisler, G. Touzet, L. Defebvre, D. Devos, C. Moreau (Lille, France)
Can we stage tau pathology in PSP?

G. Kovacs, M. Lukic, D. Irwin, T. Arzberger, G. Respondek, E. Lee, D. Coughlin, A. Giese, M. Grossman, C. Kurz, C. McMillan, E. Gelpi, Y. Compta, J. van Swieten, C. Troakes, S. Al-Sarraj, J. Robinson, S. Roeber, S. Xie, V. Lee, J. Trojanowski, G. Höglinger (Phildelphia, PA, USA)
Cancerous inhibitor of protein phosphatase 2A in Parkinson’s disease

S.J Yin, C. Han, T. Wang (Wuhan, China)
Candidate plasma miRNAs and EV protein as novel biomarkers in Parkinson’s disease patients with cognitive impairment and dementia

R.M Wu, Y.Z Tsai, M.C Kuo, Y.u Yoshioka, K.j Ueda, T.k Ochiya, S.P Lin (Taipei, Taiwan)
Canine Aromatic Detection of Parkinson’s Disease: Can Dogs Identify Prodromal Parkinsonism?

L. Mischley, J. Farahnik (Lake Forest Park, WA, USA)
CAPN1 mutations are more common than expected in patients with hereditary spastic paraparesis

G. Baille, A. Degardin, I. Strubi-Vuillaume, C. Tard (Lille, France)
Cardiac Autonomic Dysfunction in Patients with Multiple System Atrophy: A cross-sectional study

G. Ganagarajan, T.N Sathyaprabha, K. Udupa, M.R Raghurama, K. Kuravatti, B.S Prasad, R. Yadav, K. Kambhampati, P. John (Bangalore, India)
Cardiac Dysautonomia in Parkinson’s Disease

A. Carwin, S. Miri, S. Nakano, M. Anjum, E. Mundel, J. Starr, C. Marsh, B. Wilmarth, M. Arellano, H. Howard, M. Hebron, Y. Torres-Yaghi, C. Moussa, F. Pagan (Washington, DC, USA)
Cardiac Safety of PBT434, an Inhibitor of Alpha-Synuclein Aggregation for the Treatment of Multiple System Atrophy (MSA)

D. Stamler, M. Bradbury, C. Wong, E. Offman (Newark, CA, USA)
Cardiovascular Fitness, Plasma Biomarkers and Dopaminergic Denervation in Parkinson’s Disease

J. Morley, J. Dubroff, G. Cheng, B. Taylor, S. Wood, J. Duda (Philadelphia, PA, USA)
Cardiovascular risk factors in a pre-manifest and manifest population of Huntington’s disease

E. Gatto, N. Gonzalez Rojas, M. Cesarini, J. Etcheverry, G. Da Prat (Buenos Aires, Argentina)
Care-giver Burden in Parkinson’s Disease and Atypical Parkinsonism in Indian Patients Using Zarit Burden Interview scale

D. Hoskere Sreenivasa, M. Philip, P. Kukkle (Bangalore, India)
Carers of People Living with Parkinson’s Disease, the 2019 European Realities

H. Rossinot, P.M Martin, P. Odin, K.R Chaudhuri, C. Billoet, S. Lindwall (Nancy, France)
Case of percussionist dystonia in playing the janggu, a traditional Korean percussive instrument

S.K Song, J.H Kang (Jejusi, Republic of Korea)
Case Report: Pseudoatetosis as Manifestation of the Vitamin B12 Deficit

J. Vargas (Bogotá, Colombia)
Case series of unilateral subthalamotomy through implanted deep electrodes: rescue therapy in Parkinson’s disease patients submitted to deep brain stimulation surgery

L. Azevedo Kauppila, S. Parreira, M. Rosa, L. Correia Guedes, H. Carvalho, B. Cattoni, M. Coelho (Lisboa, Portugal)
Caspr2 antibody associated spinal myoclonus

S. Duma, V. Fung, R. Dhanapalaratnam, A. Martin, T. Ong, L. Allport (Kogarah, Australia)
Catatonia, Parkinsonism and Dystonia in a patient with Osmotic Demyelination Syndrome

T. Ali, G. Keeton, T. Yamasaki, Z. Guduru (Lexington, KY, USA)
CBIT Response in Clinical Practice: The Potential Importance of Comorbidities and Tic location

S. Chiu, K. Au, W. Deeb, L. Almeida, H. Simpson, M. Okun, I. Malaty (Gainesville, FL, USA)
Ceftriaxone improves motor function in a rat hemi-parkinsonian model: Potential to delay bilateral progression of motor deficits in Parkinson’s disease

E. Kasanga, C. McElroy, M. Salvatore (Fort Worth, TX, USA)
Cerebellar deep brain stimulation for secondary dystonia: A Case Report

S.Z Lin, H.X Li, CC. Zhang, Y.H Wang, Y.W Wu, D.Y Li (Shanghai, China)
Cerebellar structural covariance networks in young people with Tourette syndrome

H. Sigurdsson, S. Jackson, L. Jolley, E. Mitchell, G. Jackson (Nottingham, United Kingdom)
Cerebral microvascular injury provoked by alpha-synuclein preformed fibrils exacerbates cognitive dysfunction in Parkinson’s disease

Q.X Zhang, Y.Y Gao, L.J Wang (Guangzhou, China)
Cerebrospinal fluid protein markers of cognition in early Parkinson’s disease

I. Markaki, S. Bergström, P. Tsitsi, J. Remnestål, A. Månberg, E. Hertz, W. Paslawski, M. Uhlen, G. Mangone, S. Carvalho, O. Rascol, W. Meissner, E. Magnin, U. Wüllner, J.C Corvol, P. Nilsson, P. Svenningsson (Besancon, France)
Cerebrotendinous Xanthomatosis Tremor Successfully Controlled post-VIM-Deep Brain Stimulation

S. De Jesus, J. Davanzo, J. McInerney, E. Farace (Hershey, PA, USA)
Challenge Point Guide: Characterizing exercises performed in multilevel Parkinson-specific community exercise classes

E. Borchers, J. Goodwin, J. Bazan-Wigle, T. McIsaac, B. Farley (Tucson, AZ, USA)
Changes in fecal microbiota composition in patients with Huntington’s disease in China

G. Du, W. Dong, Q. Yang, Y. Huang (Beijing, China)
Changes in the AKT/GSK3 pathway in the cerebellum increase susceptibility to movement disorders in a rat model of post-traumatic stress disorder

G. Ngoupaye, M. Mabandla (Durban, South Africa)
Changes of gait parameters in Parkinson disease (PD) patients who underwent Deep Brain Stimulation (DBS) Surgery: A prospective one year study

V. Karthikeayan, J. Somerset, B. Hammersley, A. Macerollo, M. Bonello (Liverpool, United Kingdom)
Characterising Oromandibular Dystonia in Multiple System Atrophy: A video analysis

Y. Thongchuam, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)
Characteristics of prescribers for Parkinson’s disease patients: A nationwide study on 2017 Medicare data

S. Miri, D. Enayati, Y. Torres-Yaghi, A. Carwin, S. Nakano, M.W Anjum, F.S Amjad, F. Pagan (Washington, DC, USA)
Characterization of ataxia in Sjogren’s syndrome

C. Jaques, M. de Moraes, E. Silva, A. Coimbra Neto, G. Franklin, A. Martinez, S. Camargos, F. Cardoso, M. França Junior, A. Nucci, H. Teive, J. Pedroso, O. Barsottini (São Paulo, Brazil)
Characterization of Lewy bodies-induced neurodegeneration and synucleopathy in wild-type mice

E. Bezard, L. Zhang, X. Yu, X. Sun, Y. Zhang, G. Ran, S. Dovero, M. Persillet, P. Fernagut, B. Dehay, C. Qin (Beijing, China)
Characterization of novel alpha-synuclein aggregation model of Parkinson’s disease

A. Singh, S. Reunanen, A. Panhelainen, M. Voutilainen (Helsinki, Finland)
Characterization of pallidal neuronal activity in X-linked dystonia-parkinsonism – a model disease for compartment degeneration in the striatum

M. Baaske, D. Rasche, C. Klein, T. Münte, C. Diesta, R. Rosales, R. Jamora, V. Tronnier, C. Moll, N. Brüggemann (Lübeck, Germany)
Characterization of striatal dopaminergic neurotransmission in the rat pre-formed fibril models of Parkinson’s disease

I. Del Priore, N. Chambers, M. Coyle, R. Fassler, J. Patterson, C. Kemp, A. Stoll, K. Miller, K. Luk, C. Sortwell, C. Bishop (Binghamton, NY, USA)
Characterization of the pattern of daily motor fluctuations in Parkinson’s disease patients based on home diaries

R. Hauser, W. Poewe, J. Ferreira, A. Lees, G. Liang, M. Fonseca, D. Magalhães, J.F Rocha, P. Soares-da-Silva (Tampa, FL, USA)
Characterization of the swallow function in Parkinson patients with or without STN DBS

T. Xie, L. Bloom, P. Warnke, W. Kang, A. Dachman, E. MacCracken (Chicago, IL, USA)
Characterizing Global Cohorts with Monogenic Parkinson’s Disease

E.J Vollstedt, S. Schaake, M. Kasten, K. Lohmann, C. Klein (Lübeck, Germany)
Characterizing the genetic architecture of Parkinson’s disease in Latinos

D. Loesch, A. Horimoto, E. Sarihan, M. Cornejo-Oliva, L. Torres, M. Inca-Martinez, P. Mazzetti, C. Cosentino, E. Dieguez, V. Raggio, A. Lescano, V. Tumas, V. Borges, H. Ferraz, C. Rieder, A. Schumacher-Schuh, B. Lopes Santos-Lobato, C. Velez-Pardo, M. Jimenez-Del-Rio, F. Lopera, P. Chana-Cuevas, W. Fernandez, G. Arboleda, H. Arboleda, C. Arboleda-Bustos, D. Yearout, C. Zabetian, T. Thornton, T. O’Connor, I. Mata (Baltimore, MD, USA)
CHCHD2 mRNA levels in erythrocyte are reduced in patients with multiple system atrophy

G.l Liu, X.d Liu, T. Feng (Beijing, China)
CHIEF-PD: Cholinesterase Inhibitor to prEvent Falls in Parkinson’s Disease

S. Neumann, J. Taylor, A. Bamford, C. Metcalfe, D.M Gaunt, A. Whone, D. Steeds, S.R Emmett, W. Hollingworth, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)
Children with Tourette syndrome show greater variability in an arm-position-matching proprioceptive task

N. Cothros, A. Medina, D. Martino, S. Dukelow, R. Hawe, A. Kirton, E. Nosratmirshekarlou, T. Pringsheim (Calgary, AB, Canada)
China’s Jidong Restless Legs Syndrome Cohort Study: Objectives, Design, and Baseline Screening

S.H Wang, X.P Wang (Shanghai, China)
Cholinergic basal forebrain atrophy and cognitive decline in advanced Parkinson’s disease

M. Cohn, V. Mutreja, M. Statucka, T. Schmitz (Toronto, ON, Canada)
Chorea: A Case Series

L. Diaz-Feliz, C. Feliz-Feliz, J. Lopez delVal, P. Garcia-Ruiz, M. Ruiz-Lopez (Madrid, Spain)
Choreoathetosis post lentiform nucleus ischemic Stroke: A unique pathology and presentation

A. Deep, B. Krishnaiah, M. Ishfaq, O. Saeed, S. Shah, S. Singh, A. Alexandrov (Memphis, TN, USA)
Chromogranin B in cerebrospinal fluid as a novel biomarker for Progressive supranuclear palsy

H. Takigawa, R. Sakata, T. Inoue-Nishida, H. Kowa, K. Namashima, R. Hanajima (Yonago, Japan)
Chronic form of Pisa syndrome after prolonged exposure to low-dose amisulpride treatment

N. Şimşek Erdem, s. Özkaynak (Antalya, Turkey)
Chronic wireless streaming of pallidal and cortical recordings in Parkinson’s disease over 1000 hours at home

C. de Hemptinne, R. Gilron, R. Perone, R. wilt, J. Anso, S. Little, I. Bledsoe, M. San Luciano, J. Ostrem, P. Starr (San Francisco, CA, USA)
Circadian rhythm alterations in an in vitro cellular model of Spinocerebellar ataxia type 17

F. Motolese, A. Casamassa, A. Vescovi, V. Di Lazzaro, J. Rosati, M. Marano (Rome, Italy)
Claims Data Analysis of Parkinson’s Disease Medication Utilization

M. Frazer, C. Blauer-Peterson, R. Sasane, S. Arcona, Y. Fang, R. Halpern (Eden Prairie, MN, USA)
Clinical and demographic characteristics of patients with Functional Movement Disorders in Spain: a Consecutive Cohort Study

C. Delgado, B. Martin, P. Rada, L. Martinez, M. Sanz, B. Borda, C. Vicente, M. Garcia, O. Franch, M. Kurtis, I. Pareés (Madrid, Spain)
Clinical and etiological aspects of movement disorders in a low-income country: Case of Mali

A. Bocoum, S.H Diallo, S. Diallo, A. Koita, Y. Maiga (Bamako, Mali)
Clinical and genetic abnormalities in patients with Friedreich’s ataxia: A genotype-phenotype correlation

I. Singh, I. Ahmed, S. Shaykya, A. Srivastava (New Delhi, India)
Clinical and Genetic Characteristics of the University of Pennsylvania Parkinson’s Disease Population: Results from the Molecular Integration in Neurological Diagnosis (MIND) Initiative

T. Tropea, N. Amari, N. Han, E. Suh, V. Van Deerlin, A. Chen-Plotkin (Philadephia, PA, USA)
Clinical and genetic profile of Familial Parkinson´s disease in Cali – Colombia

J. Orozco Velez, B. Munoz Ospina, V. Quintana-Peña, J. Valderrama-Chaparro, Y. Castaño-Pino, D. Rincón, A. Navarro, I. Hernandez-Mata (Cleveland, OH, USA)
Clinical and imagiological features in Portuguese patients with SPG7 mutations

I. Antunes Cunha, J. Afonso Ribeiro, A. Morgadinho, J. Lemos, C. Januário (Coimbra, Portugal)
Clinical and kinematic assessment of a glove-based tremor dampener in patients with essential tremor

A. Sampalli, J. Lee, P. Rizek (Toronto, ON, Canada)
Clinical and neurological features of the course of parkinsonism in the presence of chronic renal disease

S. Khudayarova, G. Rakhmatullaeva (Tashkent, Uzbekistan)
Clinical and nuclear neuroimaging features of Parkinson’s disease with dysphagia

K. Ohta, T. Nakajima (Kashiwazaki city Niigata, Japan)
Clinical and oculomotor correlates with freezing of gait in Chinese Parkinson’s disease

W. Chen, L. Wu, L. Zhao, Q. He, C.Y Jiang, Q. Xu, Y.R Dong (Shanghai, China)
Clinical and self-reported falls prediction tools in people with Parkinson’s disease

L. Almeida, H. Meira, M. Piemonte, C. Canning, S. Paul (Salvador, Brazil)
Clinical characteristics of pain in Parkinson’s disease dementia

B. Ciopleias, S. Diaconu, R. Chiujdea, C. Falup-Pecurariu (Braşov, Romania)
Clinical characterization and disease progression in spinocerebellar ataxia type 35: A case series

C. Lin, S. Kuo (New York, NY, USA)
Clinical correlation with the Genotype of Friedreich’s Ataxia (FRDA) patients in Indian population

A.K Srivastava, I. Ahmad, P. Sharma, M. Seth, U. Shamim, I. Singh, R. Rajan, M.P Srivastava, F. Mohammad (New Delhi, India)
Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) in Parkinson’s Disease: Longitudinal Results

J. Gallagher, J. Rick, S. Xie, E. Mamikonyan, B. Deck, S. Rudovsky, A. Chen-Plotkin, N. Dahodwala, J. Morley, J. Duda, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)
Clinical Effect of Impedance Variations within Normal Limits in Parkinson’s Disease Treated with Subthalamic Deep Brain Stimulation

A.Y Yilmaz, A. Savas, C. Akbostanci (Ankara, Turkey)
Clinical factors associated with neuronal loss in the substantia nigra

R. Yilmaz, E. Bayram, C. Akbostanci (Ankara, Turkey)
Clinical features and natural course of corticobasal degeneration and progressive supranuclear palsy presenting as corticobasal syndrome

I. Aiba, M. Yoshida, T. Shimohata, Y. Hayashi, T. Sano, Y. Saito, S. Murayama, K. Hasegawa, Y. Iwasaki, M. Sakai, K. Wakabayashi, T. Komori, K. Nakashima (Nagoya, Japan)
Clinical Features of Depressive Disorders in Parkinson’s Disease: Possibilities of their Correction

A. Umarov, G. Rakhimbaeva (Tashkent, Uzbekistan)
Clinical features of impaired communication in patients with multiple system atrophy

T. Shimohata, M. Yamada, M. Hotta, Y. Ohno, H. Shibata, M. Yasunishi, Y. Suzuki, Y. Hayashi, A. Kimura (Aichi, Japan)
Clinical Implication of Stimulus Induced Dyskinesia in Pallidal Deep Brain Stimulation for Advanced Parkinson’s Disease

S.H Lee, K.W Park, S.Y Jo, Y.S Hwang, M.S Kim, S.R Jeon, S.J Chung (Seoul, Republic of Korea)
Clinical outcome of 6-pyruvoyl-tetrahydropterin synthase deficiency (PTPSd)

F. Nardecchia, F. Manti, S. Galosi, A. Burlina, D. Gueraldi, M. Donati, F. Pochiero, a. Cassio, F. Porta, M. Spada, C. Carducci, C. Carducci, S. Paci, G. Banderali, M. Schiaffino, N. Blau, V. Leuzzi (Rome, Italy)
Clinical outcomes after DBS surgery in cognitively impaired patients with PD

M. Patel, E. Staikova, D. Loring, M. DeLong, S. Triche, C. Esper, T. Wichmann, L. Scorr, L. Higginbotham, P. Aia, S. Factor, C. Buetefisch, S. Miocinovic (Atlanta, GA, USA)
Clinical profile and cerebral metabolic characteristic of cognitive impairments in multiple system atrophy

C. Shen, F.T Liu, JJ. Ge, P. Wu, C.T Zuo, J. Wang (Shanghai, China)
Clinical progression of Parkinson’s disease: insights from the NINDS common data elements

M. Lewis, E. Harkins, E. Lee, C. Stetter, B. Snyder, T. Corson, G. Du, L. Kong, X. Huang (Hershey, PA, USA)
Clinical research of serum uric acid levels in Parkinson’s disease

J.W Wu, T. Wang (Wuhan, China)
Clinician Ratings of Cognition Predict Trajectory of Cognitive Decline in Newly Diagnosed Individuals with Parkinson’s disease

F. Lopez, E. Trifilio, A. Ratajska, L. Kenney, D. Bowers (Gainesville, FL, USA)
Clock Drawing Test does not Differentiate Alzheimer’s Disease from Parkinson’s Disease Dementia

S. Tezcan Aydemir, M. Kuzu Kumcu, C. Akbostancı (Ankara, Turkey)
Clustering physical interventions for patients with Parkinson’s disease in network meta-analyses

A.K Folkerts, M. Ernst, M. Roheger, H. Liebermann-Jordanidis, F. Krohm, M. Droz, A. Adams, C. Eggers, I. Monsef, A. Dresen, N. Skoetz, E. Kalbe (Cologne, Germany)
Cognitive and functional predictors of ADL performance in persons with Parkinson’s Disease

J. Rider, J. Longhurst, M. Landers (Las Vegas, NV, USA)
Cognitive and psychiatric symptoms are associated with walking difficulties in mild Parkinson’s disease

B. Lindholm, C.H Brogårdh, P. Hagell, C.H Nilsson (Lund, Sweden)
Cognitive Differences Between Men and Women with Progressive Supranuclear Palsy

E. Bayram, J. Jankovic, S. Reich, C. Marras, Y. Bordelon, D. Shprecher, R. Dubinsky, I. Litvan (La Jolla, CA, USA)
Cognitive Fatigue from Attention Cognitive Load in Parkinson’s Disease

s. Chunamchai, P. Jagota, R. Bhidayasiri (Bangkok, Thailand)
Cognitive function and depressive symptoms among older adults with serious difficulty walking in Americans

Y. Zhang, Y. Qu, Q. Niu (Xi’an, China)
Cognitive function and quality of life in Parkinson’s disease: A cross-sectional study

Y.L Tang, X.L Liang, LL. Han, J.T Yu, J. Wang (Shanghai, China)
Cognitive impairment related networks of functional MRI in Parkinson’s disease

W. Sako, T. Abe, Y. Matsumoto, S. Haji, Y. Osaki, M. Harada, Y. Izumi (Tokushima, Japan)
Cognitive pretesting of the Functional Rating Scale 2.0 for Huntington’s disease (FuRST 2.0): An iterative process

P. Feigenbaum, R. Fuller, N. Lapelle, C. Fitzer-Attas, S. Luo, B. Tilley, M. Guttman, C. Goetz, C. Sampaio, G. Stebbins (Princeton, NJ, USA)
Cognitive profile of the COPPADIS cohort: Sociodemographic characteristics, lifestyle, neuropsychiatric and non-motor(NM) associated features and potentially treatable variables

A. Horta-Barba, S. Martinez-Horta, H. Bejr-Kasem, B. Pascual-Sedano, J. Pagonabarraga, D. Santos Garcia, T. Deus Fonticoba, S. Jesús, M. Aguilar, LL. Planellas, J. Garcia Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M.A Ávila Rivera, M.J Catalán, L. López Díaz, V. Puente, J.M Garcia Moreno, C. Borrue, B. Solano Vila, M. Alvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo Padilla, J.C Martinez Castrillo, P. Sanchez Alonso, M.G Alonso Losada, N. López Ariztegui, I. Gastón, M. Blazquez Estrada, M. Seijjo, J. Ruiz Martinez, C. Valero, M. Kurtis, O. de Fabregues-Boixar, J. Gonzalez Ardura, C. Prieto Jurczynska, P. Martinez-Martin, P. Mir, J. Kulisevsky, C. study group (Barcelona, Spain)
Cognitive profiling of patients with neurodegenerative disorders

I. Zhukova, E. Kolupaeva, N. Zhukova, O. Izhboldina, M. Nikitina, A. Latipova, S. Shtaymets, I. Mironova, Z.h Kislukhina, L. Tkachenko, A. Agasheva, D. Novotnyy (Tomsk, Russian Federation)
Combined therapy VS only levodopa therapy in a 5-years follow up cohort

C. Borrue-Fernandez, J. Alvarez -Alberca (San Sebastian Reyes, Spain)
Comparative analysis of cognitive function between unilaterally and bilaterally affected Parkinson’s disease

J. Lee, G.S Kim (Goyang-si, Republic of Korea)
Comparative analysis of the quality of life between healthy elderly people and those with Parkinson’s disease

L. Santos, A. Alonso, N. Luna, J. Greve (São Paulo, Brazil)
Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment patients with Parkinson’s disease

H. Zheng, D. Huang, C. Xu, Y. sun (Nanjing, China)
Comparative evaluation of the biomechanical analysis of gait in patients with Parkinson’s disease vs controls of the Zambrano Hellion Hospital

L.z Alvarado, H. Martínez, A. Sarreon, L. Guerrero, C. Cámara (SPGG, Mexico)
Compare the eficacy of cleaning the vallecular space by the chin down posture versus a novel maneuver

T. Riestra, G. Castro, C. Melian, A. Zingale, V. Tejada Jacob, D. Tavolini, S. Oviedo, M.B Fadil Iturralde (Rosario, Argentina)
Compared the effects of probiotics and Anti-PD particles on the behavior of Parkinson’s disease mice model

X.H Zhao, Y.B Wang, J. Yang, L.Y Zhang, H.Q Liu, H.J Sui (Shanghai, China)
Comparing the effects of rosemary and selegiline on behavioral symptoms of Parkinson’s animal model in mice

M. Modaresi (Isfahan, Islamic Republic of Iran)
Comparison between the results of two multidisciplinary health education program to improve the level of knowledge on key points for the management of motor and non-motor symptoms in people with Parkinson’s disease: a randomized clinical trial

C. Dias, T. Figueiredo, A. da Costa, E. Okamoto, M. Piemonte (São Paulo, Brazil)
Comparison of 123I-MIBG myocardial scintigraphy and 123I-FP-CIT SPECT between dementia with Lewy bodies and Parkinson’s disease

Y. Asahara, S. Miyagawa, M. Suzuki (Tokyo, Japan)
Comparison of accelerometers used for measurement of upper body postural tremor, and gait and balance

P. Kelly, C. Huang, R. Ellis (New York, NY, USA)
Comparison of Categorical- and Verbatim-Reported Postural Instability Symptoms Among Fox Insight Parkinson Research Participants

M. Javidnia, L. Arbatti, A. Hosamath, S. Eberly, D. Oakes, A. Nguyen, I. Shoulson (Rochester, NY, USA)
Comparison of Dystonia Rating Scales in Children with Primary (Isolated) Dystonia

M. Masten, J. Mink (Rochester, NY, USA)
Comparison of gait measures in a clinic and a community setting in people with and without Parkinson’s disease

V. Shah, J. McNames, M. Mancini, P. Carlson-Kuhta, J. Nutt, M. El Gohary, C. Curtze, F. Horak (Portland, OR, USA)
Comparison of gait pattern characteristics during Parkinson’s disease progression – Analysis of gait during the dual-task walking

S. Radovanovic, V. Markovic, I. Stankovic, S. Gluscevic, I. Petrovic, V. Kostic (Belgrade, Serbia)
Comparison of omnidirectional versus unidirectional STN-DBS – Impact on gait and balance in Parkinson’s disease

M. Kirsten, A. Gulberti, E. Gülke, C. Buhmann, W. Hamel, C. Moll, C. Gerloff, M. Pötter-Nerger (Hamburg, Germany)
Comparison of Safety and Tolerability of Deutetrabenazine (DTBZ) During Titration and Maintenance in Patients With Tardive Dyskinesia (TD)

K. Anderson, H. Fernandez, H. Barkay, A. Wilhelm, N. Chaijale, A. Send, J.M Savola, M. Gordon (Washington, DC, USA)
Comparison of the effect of hydroalcoholic extract of olive leaf and levodopa on reducing parkinson’s symptoms in animal model

M. Modaresi (Isfahan, Islamic Republic of Iran)
Comparisons of motor and non-motor features between essential tremor with and without head tremor patiens

J.X Peng, L. Wang, NN. Li, J.Y Li, L.R Duan, C.L Chen, R. Peng (Chengdu, China)
Compartment-specific blockade of dopamine uptake in nigrostriatal pathway reveals role for nigral dopamine function in movement frequency in open-field

M. Salvatore, E. Kasanga, K. Lanza, S. Meadows, A. Centner, C. Bishop (Fort Worth, TX, USA)
Complex differential diagnosis in a young-onset dementia case, leading to behavioral-variant frontotemporal dementia

O. Obrisca, O. Lacatus, O. Mihalcea, A. Dimancea, A. Ene, A.O Bajenaru (Bucharest, Romania)
Complex patterns of dyskinesias in patients chronically treated with enterally administered levodopa/carbidopa gel

A. Franco Salinas, L. Ruiz-escribano Menchén, J. Cabello, M. Gallardo Alcañiz, J. Vaamonde Gamo, R. Ibáñez Alonso, A. Camacho Nieto (Ciudad Real, Spain)
Complicated hereditary spastic paraplegia like presentation of homozygous c.2222G>A mutation in PLA2G6

V. Holla, A. Stezin, S. Prasad, S. Chaithra, K. Neeraja, N. Kamble, P. Pal, R. Yadav (Bengaluru, India)
Comprehensive Screening of Genetic, Genomic, Mitochondrial, and Microbiome Associations with Phenotypic Measures in the Dominican Republic PKAN Cohort

C. Muniz, S. Baser, C. Bass, R. Ericson, A. Espinoza, I. Ojukwu, A. Brindle, M. Santana Jimenez, F. Middleton (Santo Domingo, Dominican Republic)
Concerns in patients with Parkinson’s disease in China: A content analysis of data from social listening

Y. Qian, X. Yang, S. Xu, X. He, Y. Zhang, C. Mo, Q. Xiao (Shanghai, China)
Concordance of different evaluation approaches of non-motor symptoms in patients with cervical dystonia

V. Han, K. Kulcsarova, J. Ventosa, Z. Gdovinova, M. Skorvanek (Kosice, Slovakia)
Concurrent SCA3 and SCA10 in a young man with ataxia and prominent dystonia

A. Badiei, R. Saunders-Pullman, I. Bledsoe (San Francisco, CA, USA)
Confrontation Naming Deficit in Lewy Body Dementia Patients with Alzheimer’s Disease Co-Pathology

E. Howard, D. Irwin, K. Rascovsky, N. Nevler, S. Shellikeri, D. Mechanic-Hamilton, T. Tropea, A. Chen-Plotkin, A. Siderowf, D. Weintraub, L. Shaw, J. Trojanowski, M. Grossman, K. Cousins (Philadelphia, PA, USA)
Connecting digital mobility outcomes with clinical assessments in disorders such as Parkinson’s disease: the Mobilise-D study

W. Maetzler, A. Yarnall, I. Neatrour, A. Nieuwboer, B. Caulfield, A. Mirelman, C. Schlenstedt, C. Hansen, H. Gaßner, M. Jackson, F. Kluge, D. Berg, J. Hausdorff, J. Klucken, L. Granovsky, K. Emmert, R. Roubenoff, C. Becker, L. Rochester (Kiel, Germany)
Contribution of coding/noncoding variants in NUS1 to late-onset sporadic Parkinson’s disease

L. Jiang, H. Pan, Y. Zhao, Q. Zeng, Z. Liu, Q. Sun, Q. Xu, J. Tan, X. Yan, J. Li, B. Tang, J. Guo (Changsha, China)
Convolutional neural network for discriminating between Multiple System Atrophy and Healthy Control, comparing MRI modalities and highlighting the disease signature

E. Villain, F. Nemmi, A. Pavy-Le Traon, W. Meissner, O. Rascol, M.V Le Lann, X. Franceries, P. Péran (Toulouse, France)
Cooper-deficiency myeloneuropathy in Wilson´s Disease as a result of D-penicillamine treatment: A case report

A. Gomes, F. Rolim, K. Menezes, L. Brito, A. Moura, J. Lima, A. Marinho, G. Ferreira, F. Carvalho (Fortaleza, Brazil)
Copper induced neurobehavioral features of Parkinson’s disease and oxidative stress and their abatement by Eugenol

A. Kumar, B. Sharma (Allahabad, India)
Correlation and comparison of the lipid profile and the body fat mass in people with Parkinson’s disease submitted to three physical therapies

A.F Fagundes, E.M Monteiro, M.C Casal, M.D Delabary, A.Z Zanardi, F.B Boeno, S.M Munhoz, R.M de Menezes, A.O de Oliveira, F.M Martinez, L.T Tartaruga, A.H Haas (Porto Alegre, Brazil)
Correlation Between Dyskinesia and Quality of Life at Baseline and After 12 months of Treatment with LCIG in Patients with Advanced Parkinson’s Disease

J. L Aldred, F. E Pontieri, L. Bergmann, T. Gao, P. Kukreja, P. Bourgeois, N. Kovács (Spokane, WA, USA)
Correlation between location of active contacts and weight gain after subthalamic nucleus deep brain stimulation in Parkinson’s disease

K. Eguchi, I. Yabe, S. Shirai, M. Matsushima, T. Kano, K. Yamazaki, S. Hamauchi, T. Sasamori, K. Hirata, T. Seki, M. Kitagawa, M. Otsuki, T. Shiga, K. Hokin, H. Sasaki (Sapporo, Japan)
Correlation of brain activity measured using quantitative electroencephalography and cognitive function in patients with de novo Parkinson’s disease

Y.S Kim, S.M Kim, H.W Shin, Y.C Youn, S.W Kang (Seoul, Republic of Korea)
Correlation of Lead Location with Clinical Outcomes in a Double-Blinded Randomized Controlled Trial Evaluating Subthalamic Deep Brain Stimulation in Parkinson’s Disease (INTREPID)

J. Vitek, R. Jain, R. Woon, L. Chen, P. Starr (Minneapolis, MN, USA)
Correlations between amantadine usage, gait, and cognition in PSP: a post hoc analysis of the davunetide trial

M. Dale, B. Brumbach, A. Hiller (Portland, OR, USA)
Cortical Activation during Dynamic Sway of young Fragile X Premutation Carriers

C. O'Keeffe, M. Carro Domínguez, E. O'Rourke, T. Lynch, T. Reilly (Dublin, Ireland)
Cortical network fingerprint and prediction of deep brain stimulation-induced speech impairment in essential tremor

J.N Petry-Schmelzer, H. Jergas, T. Thies, J. Steffen, P. Reker, H. Dafsari, D. Mücke, G. Fink, V. Visser-Vandewalle, T. Dembek, M. Barbe (Cologne, Germany)
Cortical pathology in Glucocerebrosidase mutation carriers with anxiety: An MRI study

E. de Natale, H. Wilson, M. Politis (London, United Kingdom)
Cortical thickness and volume to automatically identify Parkinson’s patients using SVM

L. Squarcina, G. Dossi, M. Rango (Milan, Italy)
Cost-Analysis of the Use of IncobotulinumtoxinA and AbobotulinumtoxinA for the Treatment of Post-Stroke Upper Limb Spasticity Based on Recommended Dosing for Muscles and Clinical Patterns

M.E Gendron, D. Vézina (Burlington, ON, Canada)
Cost-Utility Analysis of Flexible Intervals with IncobotulinumtoxinA Versus Fixed Dosing with OnabotulinumtoxinA in the Management of Cervical Dystonia and Blepharospasm in Major Canadian Markets

M.E Gendron, R. Kazerooni, D. Vézina (Burlington, ON, Canada)
Cranial functional movement disorders: Clinical features, associated conditions and precipitating factors

S. Pandey, A. Mishra (New Delhi, India)
Creating moments that matter – A person-centered approach for the geriatric patient at the Parkinson Unit at Vrinnevi Hospital, Norrköping, Sweden

F. Nilsson, L. Holmberg (Norrköping, Sweden)
Creating National Competencies in Physical Activity for Exercise Professionals Working with People with Parkinson’s Disease

L. Hoffman, M. Rafferty (New York, NY, USA)
Cross-linguistic exploration of speech treatment for Parkinson’s disease: is a universal speech treatment approach plausible?

C. Fox (Tucson, AZ, USA)
CSF inflammatory cytokines and correlation with clinical features in early, untreated PD patients

E. Olivola, M. Stampanoni Bassi, L. Gilio, C. Femiano, G. Ricciardo Rizzo, F. Sica, L. Belli, R. Furlan, A. Finardi, D. Centonze, N. Modugno (Pozzilli, Italy)
Cultural disparities in deep brain stimulation (DBS) decision making in patients with Parkinson’s disease (PD): Updates

R. Shirane, M. Nisson, E. Moran, V. Shanker, C. Palmese (New York, NY, USA)
Customizing Rehabilitation based on oromotor function assessed with dynamic MRI in early Parkinson’s disease

S.G Gudwani, K.S Sharma, P.U Upadhyay, S.K Kumaran, R.S Sagar, R.D Dhamija (New Delhi, India)
CVT-301 treatment provides consistent and clinically significant improvements in Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) over 12 weeks

A. Ellenbogen, A. Corbin, P. Zhao, D. Kegler-Ebo, H. Roberts (Bingham Farms, MI, USA)
Cytokines and Brain Specific Antibodies in Experimental Cellular and Molecular Treatment of Huntington’s Diseases

D. Labunskiy, S. Kiryukhina, V. Podsevatkin (Saransk, Russian Federation)